1. Home
  2. CRBU vs AEYE Comparison

CRBU vs AEYE Comparison

Compare CRBU & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.75

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Logo AudioEye Inc.

AEYE

AudioEye Inc.

HOLD

Current Price

$7.36

Market Cap

170.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBU
AEYE
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
203.9M
170.9M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
CRBU
AEYE
Price
$1.75
$7.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$10.00
$20.67
AVG Volume (30 Days)
1.4M
151.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.00
EPS
N/A
N/A
Revenue
N/A
$35,201,000.00
Revenue This Year
N/A
$16.81
Revenue Next Year
$5.37
$11.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.41
52 Week Low
$0.66
$6.35
52 Week High
$3.53
$16.39

Technical Indicators

Market Signals
Indicator
CRBU
AEYE
Relative Strength Index (RSI) 50.32 43.68
Support Level $1.71 $6.35
Resistance Level $2.11 $12.82
Average True Range (ATR) 0.15 0.45
MACD 0.01 0.14
Stochastic Oscillator 36.00 81.67

Price Performance

Historical Comparison
CRBU
AEYE

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About AEYE AudioEye Inc.

AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.

Share on Social Networks: